Biotechnology

Techseriesinsight > Blog > News > Biotechnology

Prime Healthcare Expands Mission in Illinois

January 8, 2026
Business Wire
Biotechnology, News

During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media

More than 3,000 leaders within biotechnology are registered to attend Biotech Showcase 2026 during J.P. Morgan Healthcare Week for unmatched opportunity to forge critical investment and partnering relationships as well as...

January 7, 2026
Business Wire
Biotechnology, News

Corsera Health Announces $80 Million Series A Financing and Reaches Key Clinical Milestone

Corsera Health, Inc., a clinical-stage company leading the future of cardiovascular health through prediction and prevention, announced it has raised $80 million in a Series A financing. Forbion and...

January 7, 2026
Business Wire
Biotechnology, News

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO® (plozasiran) for the reduction of triglyceride levels in adult patients with familial...

December 23, 2025
Business Wire
Biotechnology, News

Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus balstilimab...

December 15, 2025
Business Wire
Biotechnology, News

NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation

A leading provider of oncology diagnostic solutions that enable precision medicine, today announced that Natera voluntarily dismissed its appeal (and NeoGenomics thus dismissed its cross-appeal) of the North Carolina...

December 12, 2025
Business Wire
Biotechnology, News

Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

The first publicly traded company to leverage Canton Coin (“CC”) to support the Canton Network’s ability to digitize traditional financial markets, today announced the appointment of seasoned financial executive...

December 11, 2025
Business Wire
Biotechnology, News

Zegenex Secures Social-Impact Investment from Richard King Mellon Foundation to Accelerate Breakthrough Wound Healing Solution

A biotechnology company specializing in innovative healing solutions, announced it has received a $215,000 social-mission investment from the Richard King Mellon Foundation. The funding will support formulation optimization and...

December 9, 2025
Business Wire
Biotechnology, News

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

A world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey,...

December 8, 2025
Business Wire
Biotechnology, News

Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine

Kallyope, a late-stage biotechnology company leveraging unique insights into neural signaling pathways to develop innovative therapies for migraine and metabolism, today announced positive results from a Phase 2b study...

December 4, 2025
Business Wire
Biotechnology, News

Sunbird Bio Presents New Clinical Data Supporting the Accuracy of its Blood-Based Alpha-Synuclein Assay for Parkinson’s Disease Detection

Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders, announced new data demonstrating that the company’s blood-based sunbird αSyn™ assay accurately...